Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, the Americas, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test. In addition, the company offers Gut Detective, a comprehensive stool biomarker panel used to investigate key areas of gut health, including inflammation, digestive enzyme production and intestinal permeability; and CNS Lab, which provides laboratory services for food sensitivity. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc is based in London, the United Kingdom.…
Cambridge Nutritional Sciences Share Price - CNSL, RNS News, Articles, Quotes, & Charts (LON:CNSL)
Cambridge Nutritional Sciences (LON: CNSL) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 85 employees.
The shares were at 1.450 GBp on 20 November 2026, down 35.6% over 52 weeks. Its 52-week range is 1.255 GBp to 2.500 GBp: the price is 42.0% below the high and 15.5% above the low.
Its market capitalisation is 3.45M GBP.
Cambridge Nutritional Sciences reports return on equity of -102.6%, an operating margin of -31.5% and revenue down 38.9% year over year.
It holds more cash than debt, a net cash position of 1.76M GBP. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 3.000 GBp is 106.9% above the current price.
No upcoming events tracked.